Fierce Healthcare November 6, 2018
Evan Sweeney

CVS expects to close its deal with Aetna this month, with savings expected to exceed $750 million over the next two years.

CVS Health expects to close its $69 billion acquisition of Aetna in the next two weeks, with regulatory approval anticipated from the final five states.

The company expects the deal to close by Thanksgiving. The merger was cleared by federal antitrust regulators last month contingent on Aetna selling its Part D business to WellCare.

CEO Larry Merlo said the company has already “reached an agreement on all material terms” with California regulators, and he anticipated the state would grant formal approval this week once the paperwork is finalized.

He added that CVS was “pretty far down the road”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Provider, Retail care, Trends
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Concerns raised over Indiana hospital merger
Medtronic buys surgical instrument developer Fortimedix

Share This Article